Xiaoqing Cai Selected Research

Xiaoqing Cai Research Topics

Disease

12	Neoplasms (Cancer) 03/2024 - 03/2012
4	Type 2 Diabetes Mellitus (MODY) 02/2024 - 01/2016
3	Infections 05/2023 - 04/2015
3	Cocaine-Related Disorders (Cocaine Addiction) 10/2014 - 02/2013
2	Breast Neoplasms (Breast Cancer) 09/2023 - 01/2022
2	Hyperglycemia 10/2019 - 06/2014
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2015 - 04/2010
2	Reperfusion Injury 06/2015 - 04/2010
2	Infarction (Infarctions) 06/2015 - 02/2015
2	Myocardial Infarction 02/2015 - 04/2010
2	Burns 06/2014 - 01/2013
2	Insulin Resistance 06/2014 - 04/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2010 - 12/2008
1	Obesity 02/2024
1	Critical Illness (Critically Ill) 01/2024
1	COVID-19 01/2024
1	Inflammation (Inflammations) 07/2023
1	Wounds and Injuries (Trauma) 05/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Papillomavirus Infections 12/2022
1	Anemia 03/2021
1	Hemorrhage 03/2021
1	Coronary Disease (Coronary Heart Disease) 12/2020
1	Crohn Disease (Crohn's Disease) 12/2020
1	Weight Loss (Weight Reduction) 02/2020
1	Osteoporosis 12/2019
1	Hypoparathyroidism 12/2019
1	Hypoglycemia (Reactive Hypoglycemia) 10/2019
1	Mouth Neoplasms (Oral Cancer) 01/2018
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 04/2016
1	Metrorrhagia (Spotting) 04/2016
1	Bacterial Infections (Bacterial Infection) 04/2015
1	Pseudomonas Infections 04/2015
1	Eye Diseases (Eye Disease) 04/2015
1	Myocardial Reperfusion Injury 02/2015

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 07/2023 - 01/2020
3	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2014
3	Insulin (Novolin)FDA Link 02/2015 - 04/2010
2	AntibodiesIBA 01/2023 - 01/2022
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2019 - 01/2017
2	Heparin (Liquaemin)FDA LinkGeneric 01/2017 - 03/2012
2	Glucagon Receptors (Glucagon Receptor)IBA 01/2017 - 01/2016
2	CurcuminIBA 06/2016 - 04/2015
2	GoldIBA 04/2016 - 03/2012
2	hydroxide ionIBA 02/2010 - 12/2008
2	FullerenesIBA 02/2010 - 12/2008
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2024
1	CytokinesIBA 01/2024
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2023
1	Docetaxel (Taxotere)FDA Link 09/2023
1	Melanocortin Receptors (Melanocortin Receptor)IBA 07/2023
1	MelanocortinsIBA 07/2023
1	HydrogenIBA 05/2023
1	Cyclic PeptidesIBA 01/2023
1	elastin-binding proteinsIBA 01/2023
1	ElastinIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 12/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)IBA 01/2022
1	trastuzumab deruxtecanIBA 01/2022
1	disitamab vedotinIBA 01/2022
1	Maytansine (Maitansine)IBA 01/2022
1	GinsenosidesIBA 03/2021
1	Therapeutic UsesIBA 03/2021
1	Long Noncoding RNAIBA 12/2020
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 12/2020
1	Proglucagon (Glucagon Precursors)IBA 12/2020
1	Glucagon-Like Peptides (Enteroglucagon)IBA 12/2020
1	LigandsIBA 02/2020
1	GTP-Binding Proteins (G-Protein)IBA 02/2020
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 02/2020
1	lorcaserinIBA 02/2020
1	Nanoparticle Drug Delivery SystemIBA 02/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	CalciumIBA 12/2019
1	Parathyroid Hormone (Parathormone)IBA 12/2019
1	GlucokinaseIBA 10/2019
1	polyphyllin VIIIBA 01/2018
1	Glucagon (Glukagon)FDA Link 01/2017
1	MicellesIBA 06/2016
1	DNA (Deoxyribonucleic Acid)IBA 04/2016
1	PolymersIBA 04/2016
1	Etanercept (Enbrel)FDA Link 06/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2015
1	AdiponectinIBA 06/2015
1	ProdrugsIBA 04/2015
1	Virulence Factors (Pathogenicity Factors)IBA 04/2015
1	PolyphenolsIBA 04/2015
1	Cytochromes c (Cytochrome c)IBA 02/2015

Therapy/Procedure

9	Therapeutics 03/2024 - 12/2008
4	Drug Therapy (Chemotherapy) 01/2024 - 06/2016
2	Immunotherapy 03/2024 - 01/2024
1	Photochemotherapy (Photodynamic Therapy) 01/2024
1	Photothermal Therapy 01/2024
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024
1	Radiotherapy 03/2021
1	Percutaneous Coronary Intervention 12/2020